Published Date: 04 Mar 2023
Germany: A recent study shows that female hormone therapy increases the risk of cerebral hemorrhage in patients with cerebral hemorrhage.
Read Full NewsExplore anticipated FDA decisions on groundbreaking neurology drugs in 2026, shaping treatment options for various neurologic conditions.
As part of NeurologyLive®'s Year in Review, take a look at some of the top ongoing clinical trials in Alzheimer disease and dementia that may impact care.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 2, 2026.
Psychiatry in 2025: Year in Review
Gastroenterology in 2025: Year in Review
Weight-Adjusted Waist Index Predicts Cardiovascular Risk in Patients with T2D
1.
AI-based liquid biopsy shows promise for detecting brain cancer
2.
Novel probes to label macrophages associated with cancer progression using a selective dye
3.
A Lot Can Be Said About You by Including Yourself in Photos.
4.
New methods show how fast breast cancers grow and how surgery delays affect cancer staging
5.
Telehealth in the pandemic era resulted in fewer therapy interruptions.
1.
The Benefits and Risks of Cervical Conization
2.
Impact of Hormone Therapy Cessation on Tumor Growth: Case Study of Ki-67 Reduction
3.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
4.
The Immune Revolution: Neoantigen Vaccines and the Dawn of Personalized Cancer Therapy in 2025
5.
A New Hope: Exploring the Benefits of Exenteration for Cancer Patients
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
2.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
3.
Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective
5.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation